Foley Todd
- SEC CIK
- 0001473930
In the past year, 1 open-market purchase filing worth $4.19M and 3 sale filings worth $3.14M.
Current role at each company
- TRDA Entrada Therapeutics, Inc.10% Owneras of Sep 9, 2026
- AKTS Aktis Oncology, Inc.Director, 10% Owneras of Jan 14, 2026
- ITOS iTeos Therapeutics, Inc.Other: Former 10% Owneras of May 15, 2025
- HOWL Werewolf Therapeutics, Inc.10% Owneras of Apr 30, 2025
- RPTX Repare Therapeutics Inc.Directoras of Jun 12, 2023
Show 2 more companies
- TCRR TCR2 Therapeutics Inc.10% Owneras of Jun 5, 2023
- Chiasma, IncDirectoras of Aug 5, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $4.19M
- 1 filing
- Sold
- $3.14M
- 3 filings
- Net
- +$1.05M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Foley Todd as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TRDA Entrada Therapeutics, Inc.
10% Owner6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 4, 2021 (view filing) | Nov 2 | 2 days | Foley ToddDirector, 10% Owner | PPurchase | +100.0K | $20.00 | +$2.00M | +2.3%4.43M after | |
| Dec 12, 2024 (view filing)5:00 PM ET | Dec 10-11 | 2 days | Gadicke Ansbert and 9 others10% Owner | SSale | −44.7K | $20.51 | −$917.1K | −1.0%4.38M after | 2 lots |
| Aug 26, 2026 (view filing)9:28 PM ET | Aug 24-26 | 2 days | Gadicke Ansbert and 9 others10% Owner | SSale | −62.7K | $7.36 | −$461.5K | −1.4%4.32M after | 3 lotsDuplicate filing |
| Aug 31, 2026 (view filing)6:25 PM ET | Aug 27-31 | 4 days | Gadicke Ansbert and 9 others10% Owner | SSale | −86.9K | $7.08 | −$615.8K | −2.0%4.23M after | 3 lots |
| Sep 3, 2026 (view filing)7:21 PM ET | Sep 1-3 | 2 days | Gadicke Ansbert and 9 others10% Owner | SSale | −86.5K | $7.14 | −$617.4K | −2.0%4.14M after | 3 lots |
| Sep 9, 2026 (view filing)7:23 PM ET | Sep 4-9 | 5 days | Gadicke Ansbert and 9 others10% Owner | SSale | −259.8K | $7.33 | −$1.91M | −6.3%3.89M after | 3 lots |
AKTS Aktis Oncology, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 14, 2026 (view filing) | Jan 12 | 2 days | Foley ToddDirector, 10% Owner | PPurchase | +232.9K | $18.00 | +$4.19M | +5.8%4.24M after |
ITOS iTeos Therapeutics, Inc.
Other: Former 10% Owner17 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2021 (view filing)7:13 PM ET | Sep 7-8 | 1 day | Evnin Luke and 8 others10% Owner | SSale | −42.6K | $29.03 | −$1.24M | −1.2%3.59M after | 3 lotsDuplicate filing |
| Sep 13, 2021 (view filing)7:01 PM ET | Sep 9-13 | 4 days | Evnin Luke and 8 others10% Owner | SSale | −57.6K | $28.32 | −$1.63M | −1.6%3.53M after | 4 lotsDuplicate filing |
| Sep 16, 2021 (view filing)4:48 PM ET | Sep 14-15 | 2 days | Evnin Luke and 8 others10% Owner | SSale | −45.7K | $27.70 | −$1.26M | −1.3%3.49M after | 4 lotsDuplicate filing |
| Sep 20, 2021 (view filing)6:38 PM ET | Sep 16-20 | 4 days | Evnin Luke and 8 others10% Owner | SSale | −91.3K | $28.38 | −$2.59M | −2.6%3.40M after | 4 lotsDuplicate filing |
| Sep 23, 2021 (view filing)4:19 PM ET | Sep 21-22 | 2 days | Evnin Luke and 8 others10% Owner | SSale | −33.9K | $27.50 | −$933.0K | −1.0%3.36M after | 2 lots |
| Sep 27, 2021 (view filing)5:51 PM ET | Sep 23-27 | 4 days | Evnin Luke and 8 others10% Owner | SSale | −53.5K | $27.76 | −$1.48M | −1.6%3.31M after | 4 lots |
| Sep 30, 2021 (view filing)5:06 PM ET | Sep 28-30 | 2 days | Evnin Luke and 8 others10% Owner | SSale | −21.5K | $27.00 | −$580.7K | −0.6%3.29M after | 2 lots |
| Oct 5, 2021 (view filing)4:32 PM ET | Oct 1-4 | 4 days | Evnin Luke and 8 others10% Owner | SSale | −27.6K | $27.05 | −$745.5K | −0.8%3.26M after | 2 lots |
| Oct 12, 2021 (view filing)4:34 PM ET | Oct 7-11 | 5 days | Evnin Luke and 8 others10% Owner | SSale | −52.0K | $27.23 | −$1.42M | −1.6%3.21M after | 3 lots |
| Oct 14, 2021 (view filing)5:27 PM ET | Oct 12-14 | 2 days | Evnin Luke and 8 others10% Owner | SSale | −56.8K | $27.21 | −$1.54M | −1.8%3.15M after | 3 lots |
HOWL Werewolf Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2025 (view filing)4:17 PM ET | Mar 27 | 34 daysLate | Foley Todd and 5 others10% Owner | SSale | −1.96K | $1.05 | −$2.06K | −0.1%3.21M after |
RPTX Repare Therapeutics Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 13, 2021 (view filing) | Jul 9-12 | 4 days | Foley ToddDirector | SSale | −27.4K | $33.55 | −$917.7K | −1.2%2.24M after | 3 lots |